Sorafenib in hepatocellular carcinoma: separating the hype from the hope

MeSH terms

• Antineoplastic Agents / therapeutic use*
• Benzenesulfonates / therapeutic use*
• Carcinoma, Hepatocellular / drug therapy*
• Carcinoma, Hepatocellular / mortality
• Clinical Trials, Phase II as Topic
• Clinical Trials, Phase III as Topic
• Humans
• Liver Neoplasms / drug therapy*
• Liver Neoplasms / mortality
• Niacinamide / analogs & derivatives
• Phenylurea Compounds
• Pyridines / therapeutic use*
• Randomized Controlled Trials as Topic
• Sorafenib
• Survival Rate